ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation

计划入组 203 人 · 首次发布于 2021 年 3 月 17 日

ReActiv8 Post Market Surveillance Registry

计划入组 87 人 · 首次发布于 2017 年 8 月 21 日

ReActiv8 for Chronic Low Back Pain (PMCF)

计划入组 96 人 · 首次发布于 2013 年 11 月 15 日

Reactive Red 1 Dye

C₁₉H₁₆N₈O₁₀S₃

Reactive Red 6 hapten

C₃₅H₂₅N₉O₂₂S₆

neoantigen reactive T cells

ReActiv8 Neurostimulation Shows Strong Results in RESTORE Trial for Chronic Low Back Pain

Anthem Blue Cross and Blue Shield Approves Coverage for ReActiv8 Neurostimulation Therapy for Chronic Low Back Pain

Chronic Lower Back Pain Pipeline Shows Mixed Results as Multiple Phase III Trials Report Outcomes